(Q37124951)

18 August 2017

1 reference

title

Secretory leukocyte peptidase inhibitor and lung cancer (English)

1 reference

18 August 2017

1 reference

Toshihiro Nukiwa

1

1 reference

18 August 2017

Takuji Suzuki

series ordinal

2

1 reference

18 August 2017

Tatsuro Fukuhara

series ordinal

3

1 reference

18 August 2017

Toshiaki Kikuchi

series ordinal

4

1 reference

18 August 2017

publication date

1 May 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

99

1 reference

18 August 2017

issue

5

1 reference

18 August 2017

page(s)

849-855

1 reference

Expression of the secretory leukoprotease inhibitor gene in epithelial cells

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

The role of secretory leucoprotease inhibitor in the resolution of inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Human lung project: evaluating variance of gene expression in the human lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Proteins with whey-acidic-protein motifs and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Bacterial pneumonia causes augmented expression of the secretory leukoprotease inhibitor gene in the murine lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Cis-acting region associated with lung cell-specific expression of the secretory leukoprotease inhibitor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Structure of the murine secretory leukoprotease inhibitor (Slpi) gene and chromosomal localization of the human and murine SLPI genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Comparative sequence analyses reveal rapid and divergent evolutionary changes of the WFDC locus in the primate lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Mouse SWAM1 and SWAM2 are antibacterial proteins composed of a single whey acidic protein motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Secretory Leukocyte Protease Inhibitor Binds to Annexin II, a Cofactor for Macrophage HIV-1 Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Inhibition of NF-kappaB activation and augmentation of IkappaBbeta by secretory leukocyte protease inhibitor during lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Secretory leucoprotease inhibitor impairs Toll-like receptor 2- and 4-mediated responses in monocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Scatter factor modulates the metastatic phenotype of the EMT6 mouse mammary tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Secretory leukocyte protease inhibitor mediates proliferation of human endometrial epithelial cells by positive and negative regulation of growth-associated genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Secretory leukocyte protease inhibitor in cancer development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Increased secretory leukoprotease inhibitor in patients with nonsmall cell lung carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Gene therapy with secretory leukoprotease inhibitor promoter-controlled replication-competent adenovirus for non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Profile of gene expression induced by the tumour promotor TPA in murine epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

The secretory leukocyte protease inhibitor (SLPI) suppresses cancer cell invasion but promotes blood-borne metastasis via an invasion-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

Neutrophil elastase and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00772.X

10.1111/J.1349-7006.2008.00772.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference